Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Dr. Scagliotti Discusses the Future of Lung Cancer Therapy

September 8th 2011

Dr. Giorgio V. Scagliotti from the University of Turin Discusses the Future of Lung Cancer Therapy

Dr. Rugo on Anti-Angiogenesis Therapy Response Predictors

September 7th 2011

Dr. Hope S. Rugo from University of California, San Francisco on Anti-Angiogenesis Therapy Response Predictors

Dr. Ellis on Measuring Endocrine Therapy Efficacy

September 6th 2011

Dr. Matthew J. Ellis from Washington University on Measuring Endocrine Therapy Efficacy With Ki67

4 Questions for Johan Lennartsson, PhD

September 6th 2011

Johan Lennartsson's research focuses on platelet-derived growth factor receptor (PDGFR) and mitogen-activated protein kinase (MAPK) signaling in normal physiology and cancer.

The SCF/KIT Pathway's Roles: Interest in Therapeutic Targets Is Growing

September 2nd 2011

The breadth of the stem cell factor (SCF)/ KIT signaling pathway oncogenic functions and potential role as a therapeutic target are just now becoming clear.

Dr. Tripathy on Connecting Markers to Clinical Outcomes

September 1st 2011

Dr. Debu Tripathy from the USC Norris Cancer Center on Connecting Markers to Clinical Outcomes

Georgetown Lombardi Comprehensive Cancer Center: Innovative Steps Toward Individualized Treatment

September 1st 2011

Established in 1970 as a small clinic for cancer patients, the Georgetown Lombardi Comprehensive Cancer Center was named for football coach Vince Lombardi, who was treated for cancer at Georgetown University Hospital.

Dr. Ellis on Ki67 as Treatment Monitoring Biomarkers

August 31st 2011

Dr. Matthew J. Ellis from Washington University Discusses Ki67 as a Treatment Monitoring Biomarker

Dr. O'Shaughnessy on Breast Cancer Biomarkers

August 30th 2011

Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on the Future of Breast Cancer Biomarkers

Dr. Ellis Discusses the Future of the PI3-Kinase Pathway

August 26th 2011

Dr. Matthew J. Ellis from Washington University Discusses the Future of the PI3-Kinase Pathway

Dr. Ellis Discusses the Cell-Proliferation Marker Ki67

August 24th 2011

Dr. Matthew Ellis from Washington University Discusses the Cell-Proliferation Marker Ki67

Racing Against Breast Cancer: A Conversation With Edith A. Perez, MD

August 24th 2011

It's hard to tell which moves more quickly: Edith Perez's feet, or her mind.

Dr. Reckamp on Current Heat Shock Protein Clinical Trials

August 22nd 2011

Dr. Karen Reckamp City of Hope cancer center on Current Heat Shock Protein Clinical Trials

Dr. Tripathy Discusses HER2 Targeted Therapies

August 22nd 2011

Dr. Debu Tripathy from UC Norris Cancer Center Discusses HER2 Targeted Therapies

PERSONALIZED CANCER CARE5 Key Areas Where Biomarkers Point the Way to Personalized Care

August 22nd 2011

Biological markers that help clinicians choose which treatment options to pursue for particular patients are attracting increased research interest.

Dr. Tripathy on Completing New Assays After Recurrence

August 18th 2011

Dr. Debu Tripathy from USC Norris Cancer Center on Completing New Assays After Recurrence

The Great Biomarker Chase: Promise & Pitfalls Along the Path to Personalized Care

August 16th 2011

Biomarkers offer great potential for improving management of cancer at every point from screening and detection, to diagnosis, staging, prognosis, and the assessment of treatment response.

Dr. Wolff Discusses the Importance of HER2 Testing

August 15th 2011

Dr. Antonio C. Wolff from Sidney Kimmel Comprehensive Cancer Center Discusses the Importance of HER2 Testing

Dr. Tripathy on the Oncotype DX Assay Recurrence Score

August 15th 2011

Dr. Debu Tripathy from USC Norris Cancer Center on the Oncotype DX Assay Recurrence Score

Dr. Tripathy Discusses Breast Cancer Gene Profiling

August 12th 2011

Dr. Debu Tripathy from USC Norris Cancer Center Discusses Breast Cancer Gene Profiling